Cecile T J Holweg Selected Research

Omalizumab (Xolair)

1/2024	Effectiveness of omalizumab across different dosing regimens in patients with moderate-to-severe allergic asthma.
1/2023	Similar response to omalizumab in children with allergic asthma from different racial backgrounds.
1/2022	Impact of body mass index on omalizumab response in adults with moderate-to-severe allergic asthma.
1/2022	Omalizumab in Asthma with Fixed Airway Obstruction: Post Hoc Analysis of EXTRA.
1/2022	Omalizumab treatment reduces asthma exacerbations regardless of airway bronchodilator reversibility.
1/2022	Defining the Efficacy of Omalizumab in Nasal Polyposis: A POLYP 1 and POLYP 2 Subgroup Analysis.
11/2021	Response to Omalizumab in Black and White Patients with Allergic Asthma.
1/2021	Omalizumab response in patients with asthma by number and type of allergen.
1/2021	No difference in omalizumab efficacy in patients with asthma by number of asthma-related and allergic comorbidities.
1/2016	Roles of Periostin in Respiratory Disorders.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cecile T J Holweg Research Topics

Disease

27	Asthma (Bronchial Asthma) 01/2024 - 08/2015
13	Inflammation (Inflammations) 01/2023 - 12/2004
2	Nasal Polyps (Nasal Polyp) 01/2022 - 12/2017
2	Airway Obstruction (Choking) 01/2022 - 10/2017
2	Rheumatoid Arthritis 12/2011 - 09/2011
2	Infections 06/2007 - 08/2006
1	Body Weight (Weight, Body) 01/2024
1	Chronic Urticaria 01/2023
1	COVID-19 11/2022
1	Symptom Flare Up 01/2022
1	Overweight 01/2022
1	Polyps 01/2022
1	Hypersensitivity (Allergy) 01/2021
1	Churg-Strauss Syndrome (Allergic Angiitis) 01/2018
1	Rhinosinusitis 12/2017
1	Aplastic Anemia (Anemia, Hypoplastic) 10/2016
1	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 10/2016
1	Eosinophilia 04/2016
1	Idiopathic Pulmonary Fibrosis 01/2016
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2016
1	Disease Progression 01/2016
1	Airway Remodeling 01/2016
1	Fibrosis (Cirrhosis) 01/2016
1	Asymptomatic Infections 08/2006
1	Vascular Diseases (Vascular Disease) 08/2006
1	Heart Failure 04/2005
1	Coronary Artery Disease (Coronary Atherosclerosis) 12/2004

Drug/Important Bio-Agent (IBA)

13	Biomarkers (Surrogate Marker)IBA 01/2023 - 09/2011
10	Omalizumab (Xolair)FDA Link 01/2024 - 01/2016
9	PeriostinIBA 01/2023 - 08/2015
9	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 08/2015
6	lebrikizumabIBA 01/2019 - 08/2015
4	Immunoglobulin E (IgE)IBA 01/2024 - 12/2017
4	Monoclonal AntibodiesIBA 01/2022 - 10/2016
3	Bronchodilator Agents (Bronchodilators)IBA 01/2022 - 10/2016
3	Interleukin-13IBA 01/2018 - 01/2016
2	AutoantibodiesIBA 01/2023 - 12/2011
2	SteroidsIBA 01/2022 - 01/2021
2	Heme Oxygenase-1IBA 04/2005 - 12/2004
1	Immunoglobulin G (IgG)IBA 01/2023
1	Henan 8204 (8204)IBA 11/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022
1	Beclomethasone (Beclometasone)FDA Link 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 01/2021
1	AllergensIBA 01/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021
1	CytokinesIBA 01/2019
1	Prednisolone (Predate)FDA LinkGeneric 01/2019
1	montelukast (Singulair)FDA Link 01/2018
1	Triglycerides (Triacylglycerol)IBA 01/2017
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2017
1	Lipoproteins (Lipoprotein)IBA 01/2017
1	LipidsIBA 01/2017
1	Interleukin-4 (Interleukin 4)IBA 01/2016
1	anti-IgE antibodiesIBA 01/2016
1	tralokinumabIBA 01/2016
1	Methotrexate (Mexate)FDA LinkGeneric 12/2011
1	Rituximab (Mabthera)FDA Link 12/2011
1	Messenger RNA (mRNA)IBA 09/2011
1	Antiviral Agents (Antivirals)IBA 06/2007
1	Viral DNAIBA 06/2007
1	DNA (Deoxyribonucleic Acid)IBA 06/2007
1	Ganciclovir (Cytovene)FDA LinkGeneric 08/2006
1	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 08/2006
1	cytomegalovirus-specific hyperimmune globulinIBA 08/2006
1	EnzymesIBA 04/2005
1	thiazole-4-carboxamide adenine dinucleotide (TCAD)IBA 12/2004

Therapy/Procedure

7	Therapeutics 01/2022 - 09/2011
2	Heart Transplantation (Grafting, Heart) 04/2005 - 12/2004
2	Transplantation 04/2005 - 12/2004
1	Drug Tapering 01/2022
1	Biological Therapy 01/2021